help button home button Am J Pathol ASIP 2008 Summer Academy, Molecular Methcanisms of Human Disease: Injury, Inflammation, and Tissue Repair
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Strayer, D. S.
Right arrow Articles by Leibowitz, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Strayer, D. S.
Right arrow Articles by Leibowitz, J. L.

American Journal of Pathology, Vol 128, 203-209, Copyright © 1987 by American Society for Investigative Pathology


REGULAR ARTICLES

Inhibition of epidermal growth factor-induced cellular proliferation

DS Strayer and JL Leibowitz

The authors tested whether two oncogenic poxviruses, Shope fibroma virus (SFV) and malignant rabbit fibroma virus (MV), coded for an epidermal growth factor (EGF)-like protein. Virus-free lysates of SFV or MV-infected rabbit kidney cells do not appreciably affect proliferation of EGF-unresponsive RK-13 cells. Comparable lysates inhibit the background proliferation of two EGF-responsive cell lines, human foreskin fibroblasts and normal rat kidney cells. Inhibition of EGF-stimulated proliferation is also observed in a dose-dependent fashion. This inhibition is greatest when the virus lysate preparations are added either simultaneously with or before EGF. When EGF is added to cultures 24 hours before the SFV or MV preparations, the latter then have little or no effect on EGF-induced target cell proliferation. The inhibitory factor competed with radiolabeled EGF for its receptor site. Electroblotting shows a protein of 35 kd molecular weight in the lysates of virus-infected RK-13 cells which reacts with anti-EGF antibody. These findings interpreted to indicate that SFV and MV code for an inhibitor of EGF activity, and that this inhibition occurs at least in part by competitive inhibition of EGF-EGF receptor interactions.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1987 by the American Society for Investigative Pathology.